Empowering Myeloid Cells to Better Address Unmet Clinical Needs

To maximize the drugability potential, we target approaches to improve clinical benefits based on reverse translational science and emerging biology of the tumor microenvironment.

  • (Reverse)Translational Science

    Clinical Experience   Basic Research

    Identification of patients' unmet needs, novel targets, pathways, and mechanisms.

  • Drug Discovery & Development

    Myeloid Engager

    Validation of target, mechanism of action, and proof of concept, and development of novel engager with high potency and good safety profile.

  • Immunotherapy

    Clinical Benefit

    Boosting of anti-tumor immunity to fight against cancer.

为了更好的呈现效果,移动端请竖屏浏览